Emilio Bajetta

26.3k citations
328 papers · 17.3k · 7 hit papers · h-index 55

Impact in

  • Oncology top 0.1%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Lung Cancer Research Studies
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • Colorectal Cancer Treatments and Studies 45
    • Cancer Treatment and Pharmacology 36
    • Lung Cancer Research Studies 31
    • Lung Cancer Treatments and Mutations 29
    • Gastric Cancer Management and Outcomes 23

Emilio Bajetta

318 papers receiving 16.5k citations

Emilio Bajetta's Hit Papers

Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival 2010 · 668 citations
6680+16+33Years since publication50010001.5k

Peers

Emilio Bajetta
Comparison fields: 5 of 141
  • Oncology 8.6k
  • Cancer Research 2.9k
  • Pulmonary and Respiratory Medicine 5.0k
  • Hepatology 625
  • Hematology 837
Replace Patrick Schöffski with:
Patrick Schöffski Belgium
Joel Picus United States
Allan T. van Oosterom Belgium
J. Milburn Jessup United States
Martin Gore United Kingdom
Christoph Zielinski Austria
Yoshitaka Fujii Japan
Filippo de Braud Italy
Afshin Dowlati United States
John Zalcberg Australia
Emilio Bajetta relative to Patrick Schöffski Belgium Patrick Schöffski's profile →
Citations per field
00.5×1.7×
Patrick Schöffski · 1×
Citations per year

Countries citing papers authored by Emilio Bajetta

Since Specialization
Citations

This map shows the geographic impact of Emilio Bajetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio Bajetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio Bajetta more than expected).

Fields of papers citing papers by Emilio Bajetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilio Bajetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio Bajetta. The network helps show where Emilio Bajetta may publish in the future.

Co-authors

The 25 scholars most cited alongside Emilio Bajetta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emilio Bajetta Line = papers co-authored together Emilio Bajetta links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 328 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Hit paper breakdown →
20071785
2
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Hit paper breakdown →
20091078
3
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Hit paper breakdown →
19761030
4
Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Hit paper breakdown →
2001822
5
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
Hit paper breakdown →
1998822
6
Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
Hit paper breakdown →
2010668
7
Interleukin-12: Biological Properties and Clinical Application
Hit paper breakdown →
2007506
8 2007464
9 2002436
10 2000431
11 2012369
12 2008345
13 2004310
14 2007272
15 2000254
16 1996250
17 1999232
18 2008206
19 2008187
20 2006180

About Emilio Bajetta

Emilio Bajetta is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Genetics, having authored 328 papers that have together received 17.3k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (53 papers), Colorectal Cancer Treatments and Studies (45 papers), Cancer Treatment and Pharmacology (36 papers), Estrogen and related hormone effects (34 papers), Lung Cancer Research Studies (31 papers), Lung Cancer Treatments and Mutations (29 papers), Neuroblastoma Research and Treatments (24 papers) and Gastric Cancer Management and Outcomes (23 papers). The work is most often cited by research in Oncology (8.6k citations), Cancer Research (2.9k citations), Pulmonary and Respiratory Medicine (5.0k citations), Hepatology (625 citations) and Hematology (837 citations). Emilio Bajetta has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Roberto Buzzoni, Sergio Bracarda, Maria Di Bartolomeo, Nicoletta Zilembo, Bernard Escudier, Gianni Bonadonna, Alain Ravaud, Bohuslav Melichar, Antonia Martinetti and Luigi Celio. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact